Skip to main content

FDA staff raises safety concerns over Trevena opioid drug

Staff reviewers of the U.S. Food and Drug Administration on Tuesday raised safety concerns over Trevena Inc's opioid injection to treat acute pain, saying the treatment has an abuse and overdose potential.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.